IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
1.210
+0.034 (2.92%)
Apr 1, 2025, 10:46 AM EDT - Market open

IceCure Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
3.293.233.094.143.87
Upgrade
Revenue Growth (YoY)
1.92%4.67%-25.45%6.98%-32.61%
Upgrade
Cost of Revenue
1.841.931.641.941.42
Upgrade
Gross Profit
1.451.31.452.22.44
Upgrade
Selling, General & Admin
10.058.69.066.042.78
Upgrade
Research & Development
7.18.279.125.883.81
Upgrade
Operating Expenses
17.1516.8818.1811.926.59
Upgrade
Operating Income
-15.7-15.58-16.74-9.72-4.14
Upgrade
Interest Expense
---0.24-0.17-
Upgrade
Interest & Investment Income
0.380.92--0.41
Upgrade
Pretax Income
-15.32-14.65-16.98-9.9-3.73
Upgrade
Net Income
-15.32-14.65-16.98-9.9-3.73
Upgrade
Net Income to Common
-15.32-14.65-16.98-9.9-3.73
Upgrade
Shares Outstanding (Basic)
5146372917
Upgrade
Shares Outstanding (Diluted)
5146372917
Upgrade
Shares Change (YoY)
11.48%23.29%29.66%66.67%25.75%
Upgrade
EPS (Basic)
-0.30-0.32-0.46-0.35-0.22
Upgrade
EPS (Diluted)
-0.30-0.32-0.46-0.35-0.22
Upgrade
Free Cash Flow
-12.63-13.03-15.18-13.14-3.91
Upgrade
Free Cash Flow Per Share
-0.25-0.29-0.41-0.46-0.23
Upgrade
Gross Margin
44.09%40.26%46.84%53.04%63.19%
Upgrade
Operating Margin
-476.94%-482.38%-542.59%-234.99%-107.08%
Upgrade
Profit Margin
-465.45%-453.76%-550.34%-239.13%-96.43%
Upgrade
Free Cash Flow Margin
-383.89%-403.53%-492.16%-317.50%-101.16%
Upgrade
EBITDA
-15.36-15.25-16.49-9.6-4.08
Upgrade
EBITDA Margin
----231.92%-105.46%
Upgrade
D&A For EBITDA
0.330.320.250.130.06
Upgrade
EBIT
-15.7-15.58-16.74-9.72-4.14
Upgrade
EBIT Margin
----234.99%-107.08%
Upgrade
Advertising Expenses
0.030.090.070.060.04
Upgrade
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q